List of works - Mark J. Olsen

A cell-surface β-hydroxylase is a biomarker and therapeutic target for hepatocellular carcinoma

scientific article

Anti-Tumor Effects of Second Generation β-Hydroxylase Inhibitors on Cholangiocarcinoma Development and Progression.

scientific article

Antibody affinity maturation using bacterial surface display.

scientific article

Aspartate β-Hydroxylase expression promotes a malignant pancreatic cellular phenotype

scientific article

Aspartate β-hydroxylase modulates cellular senescence through glycogen synthase kinase 3β in hepatocellular carcinoma

scientific article published on 19 December 2015

Development of an optimized expression system for the screening of antibody libraries displayed on the Escherichia coli surface.

scientific article

Engineering of protease variants exhibiting high catalytic activity and exquisite substrate selectivity.

scientific article published on 2 May 2005

Erratum: Benelli, R., et al. Aspartate-β-Hydroxylase: A Promising Target to Limit the Local Invasiveness of Colorectal Cancer. Cancers 2020, 12, 971

scientific article published on 13 May 2020

FTO, RNA epigenetics and epilepsy ⬇️

scientific article published on September 4, 2012

Function-based isolation of novel enzymes from a large library.

scientific article

High-throughput FACS method for directed evolution of substrate specificity.

scientific article

Modern Approaches to Quality Assurance of Drug Formulations.

scientific article published on 20 May 2015

Perspectives on the Development of Antioxidant Antiepileptogenic Agents ⬇️

scientific article published on September 1, 2012

Selection of horseradish peroxidase variants with enhanced enantioselectivity by yeast surface display.

scientific article

Synthesis of a FTO inhibitor with anticonvulsant activity.

scientific article published on 5 June 2014

The Forty-Sixth Euro Congress on Drug Synthesis and Analysis: Snapshot †.

scientific article published on 28 October 2017

List of works by Mark J. Olsen

A cell-surface β-hydroxylase is a biomarker and therapeutic target for hepatocellular carcinoma

Anti-Tumor Effects of Second Generation β-Hydroxylase Inhibitors on Cholangiocarcinoma Development and Progression.

Antibody affinity maturation using bacterial surface display.

Aspartate β-Hydroxylase expression promotes a malignant pancreatic cellular phenotype

Aspartate β-hydroxylase modulates cellular senescence through glycogen synthase kinase 3β in hepatocellular carcinoma

Development of an optimized expression system for the screening of antibody libraries displayed on the Escherichia coli surface.

Engineering of protease variants exhibiting high catalytic activity and exquisite substrate selectivity.

Erratum: Benelli, R., et al. Aspartate-β-Hydroxylase: A Promising Target to Limit the Local Invasiveness of Colorectal Cancer. Cancers 2020, 12, 971

FTO, RNA epigenetics and epilepsy ⬇️

Function-based isolation of novel enzymes from a large library.

High-throughput FACS method for directed evolution of substrate specificity.

Modern Approaches to Quality Assurance of Drug Formulations.

Perspectives on the Development of Antioxidant Antiepileptogenic Agents ⬇️

Selection of horseradish peroxidase variants with enhanced enantioselectivity by yeast surface display.

Synthesis of a FTO inhibitor with anticonvulsant activity.

The Forty-Sixth Euro Congress on Drug Synthesis and Analysis: Snapshot †.